From Pubdrug

Welcome to PubDrug - The open access drug resource

ATTENTION: We recently suffered a failure of our web host's MySQL server, resulting in a significant loss of data. We have recovered a previous stable backup from May 4, 2007. We also have a complete list of edits from that date through June 5th, which was the last time PubDrug was edited, and we have begun the process of adding those edits back into the wiki by hand. Please bear with us as we nurse PubDrug back to health. Thank you for your understanding.

We currently have a total of 17 fully-certified drug records. For information about PubDrug and our continuing development, please consult our Planning document.

Expanded Drug Monographs List, Updated April 2007

Our certified monographs include:

• Acyclovir
• Alendronate
• Amlodipine
• Atorvastatin
• Cholecalciferol
• Donepezil
• Duloxetine
• Escitalopram
• Esomeprazole
• Memantine
• Montelukast
• Pregabalin
• Sertraline
• Sildenafil
• Tadalafil
• Tramadol
• Valacyclovir

All italicized drug monographs have been added since our last update. All drug monographs in bold have been converted to the new PubDrug template.

This progress would not have been possible without the amazing efforts of a handful of fourth-year professional Pharm.D. students at the University at Buffalo. Their user pages are linked from the above records and I encourage everyone to visit them.

There are other types of PubDrug records being developed. More information will be posted here as this work progresses.

Comments about PubDrug

PubDrug was founded November 8, 2006, in an effort to develop a copyright-free, royalty-free, full-text drug resource. PubDrug's intended audience includes all health practitioners, researchers, informaticians, and the general public.

PubDrug is being developed as a wiki, allowing us to harness the expertise of the entire internet to help create this database. However, it is our intention to also apply editorial guidelines and fact-checking to help keep this data as error-free as possible.

We would like to invite you to assist us in this effort. More information will be posted here as this project continues to take shape. You may also wish to look at the proposal and our Planning document.

E-mail sbrower@buffalo.edu if you have any questions about this project and/or would like to volunteer. Visit the Pubdrug:Community_Portal for interactive discussion of the project. Watch this space for future announcements!

Note: The URL www.pubdrug.org redirects to this page currently, but is being tweaked. You may wish to bookmark the URL for this page for the time being while we work out the kinks with the redirect.